A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology

Area of Science:

• Molecular biology
• Gene therapy
• Nanomedicine

Background:

• Messenger RNA (mRNA) therapies hold significant potential, demonstrated by their use during the COVID-19 pandemic.
• The widespread application of mRNA therapeutics is hindered by a lack of effective delivery vehicles.
• Adenovirus entry mechanisms are well-understood and offer a potential basis for novel delivery systems.

Purpose of the Study:

• To explore adenovirus-based strategies for enhanced mRNA delivery.
• To investigate the efficacy of an adenovirus-polylysine (AdpL) conjugate for mRNA transport.
• To evaluate AdpL's potential for facilitating mRNA delivery to the cellular cytosol for transgene expression.

Main Methods:

• Development of an adenovirus-polylysine (AdpL) conjugate for piggyback mRNA transport.
• Utilizing adenovirus's natural entry pathways: binding, receptor-mediated endocytosis, and endosomal escape.
• In vitro and in vivo studies to assess gene transfer efficiency of AdpL mRNA vectors.

Main Results:

• AdpL successfully mediated the transport of mRNA vectors.
• Effective gene transfer was confirmed in both in vitro and in vivo experimental models.
• The AdpL system demonstrated efficient delivery of mRNA to the cellular cytosol.

Conclusions:

• Adenovirus-polylysine (AdpL) conjugates represent a viable strategy for mRNA delivery.
• This method leverages adenovirus entry biology to overcome current limitations in mRNA transport.
• AdpL holds promise for advancing mRNA-based therapeutics and actualizing their clinical potential.